Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.

Jazz Pharmaceuticals Is 25th Drugmaker to Implement Contract Pharmacy Restrictions

Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.